Polyploidy: Occurrence in nature, mechanisms, and significance for the megakaryocyte-platelet system

Experimental Hematology

Volumn 28, Issue 1, 2000, Pages 3-16

  Zimmet, Jeffrey ^a   Ravid, Katya ^a  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cell cycle; Megakaryocyte; Platelet; Polyploidy

Indexed keywords

CYCLIN D3;

ANIMAL CELL; ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; CELL CYCLE; CHRONIC LEUKEMIA; CHRONIC MYELOID LEUKEMIA; DNA SYNTHESIS; HUMAN; HUMAN CELL; MEGAKARYOCYTE; MITOSIS; MYELOPROLIFERATIVE DISORDER; NONHUMAN; POLYPLOIDY; PRIORITY JOURNAL; REVIEW; THROMBOCYTE FUNCTION;

ANIMALS; BLOOD PLATELETS; CARDIOVASCULAR DISEASES; CELL CYCLE; DIPLOIDY; DNA; HUMANS; LEUKEMIA; MEGAKARYOCYTES; MITOSIS; MYELOPROLIFERATIVE DISORDERS; POLYPLOIDY;

ANIMALIA;

EID: 0033969732     PISSN: 0301472X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0301-472X(99)00124-1     Document Type: Review

References (155)

1. Strassburger E. Chromosomenzahl. Flora. 100:1910;398.
2. Winkler H. Uber die experimentelle erzeugung von pflanzen mit abweichenden chromosomenzahlen. Z bot. 8:1916;417.
3. Sigrist S.J., Lehner C.F. Drosophila fizzy-related down-regulates mitotic cyclins and is required for cell proliferation arrest and entry into endocycles. Cell. 90:1997;671.
4. Knoblich J.A., Sauer K., Jones L., Richardson H., Saint R., Lehner C.F. Cyclin E controls S phase progression and its down-regulation during Drosophila embryogenesis is required for the arrest of cell proliferation. Cell. 77:1994;107.
5. Brodsky W.Y., Uryvaeva IV Cell polyploidy. its relation to tissue growth and function Int Rev Cytol. 50:1977;275.
6. Kudryavtsev B.N., Kudryavtseva M.V., Sakuta G.A., Stein G.I. Human hepatocyte polyploidization kinetics in the course of life cycle. Virchows Arch. 64:1993;387.
7. Owens G.K., Schwartz S.M. Vascular smooth muscle cell hypertrophy and hyperploidy in the Goldblatt hypertensive rat. Circ Res. 53:1983;491.
8. Owens G.K., Schwartz S.M. Alterations in vascular smooth muscle mass in the spontaneously hypertensive rat. Role of cellular hypertrophy, hyperploidy, and hyperplasia. GRP Circ Res. 51:1982;280.
9. Sandritter W., Scomazzoni G. Deoxyribonucleic acid content (Feulgen photometry) and dry weight (interference microscopy) of normal and hypertrophical heart muscle fibres. Nature. 202:1964;100.
10. Heiden F.L., James J. Polyploidy in the human myometrium. Z Mikroskop Anatom Forsch. 89:1975;18.
11. Gilbert P., Pfitzer P. Facultative polyploidy in endocrine tissues. Virchows Arch. 25:1977;233.
12. Auer G.U., Backdahl M., Forsslund G.M., Askensten U.G. Ploidy levels in nonneoplastic and neoplastic thyroid cells. Anal Quant Cytol Histol. 7:1985;97.
13. Sennerstam R., Auer G. Polyploidization by means of endoduplication in a human breast cancer cell line. Anal Quant Cytol Histol. 15:1993;303.
14. Barlogie B. Abnormal cellular DNA content as a marker of neoplasia. Eur J Cancer Clin Oncol. 20:1984;1123.
15. Lanza G., Gafa R., Santini A., Maestri I., Dubini A., Gilli G., Cavazzini L. Prognostic significance of DNA ploidy in patients with stage II and stage III colon carcinoma. a prospective flow cytometric study Cancer. 82:1998;49.
16. Bosari S, Lee AK, Tahan SR, Figoni MA, Wiley BD, Heatley GJ, Silverman ML (1992) DNA flow cytometric analysis and prognosis of axillary lymph node-negative breast carcinoma. Cancer 70:1943.
17. Lo J., Kerns B.J., Amling C.L., Robertson C.N., Layfield L.J. Correlation of DNA ploidy and histologic diagnosis from prostate core-needle biopsies. is DNA ploidy more sensitive than histology for the diagnosis of carcinoma in small specimens? J Surg Oncol. 63:1996;41.
18. Geitler L. Endomitose and endomitotische poltploidisierung. Protoplasmatol. 6:1953;1.
19. Romanowski P., Madine M.A. Mechanisms restricting DNA replication to once per cell cycle. MCMs, pre-replicative complexes and kinases Trends Cell Biol. 6:1996;184.
20. Rao P.N., Johnson R.T. Mammalian cell fusion. studies on the regulation of DNA synthesis and mitosis Nature. 225:1970;159.
21. Leno G.H., Downes C.S., Laskey R.A. The nuclear membrane prevents replication of human G2 nuclei but not G1 nuclei in Xenopus egg extract. Cell. 69:1992;151.
22. Blow J.J., Laskey R.A. A role for the nuclear envelope in controlling DNA replication within the cell cycle. Nature. 332:1988;546.
23. Kearsey S.E., Maiorano D., Holmes E.C., Todorov I.T. The role of MCM proteins in the cell cycle control of genome duplication. Bioessays. 18:1996;183.
24. Madine M.A., Khoo C.Y., Mills A.D., Mushal C., Laskey R.A. The nuclear envelope prevents reinitiation of replication by regulating the binding of MCM3 to chromatin in Xenopus egg extracts. Curr Biol. 5:1995;1270.
25. Kubota Y., Mimura S., Nishimoto S., Masuda T., Nojima H., Takisawa H. Licensing of DNA replication by a multi-protein complex of MCM/P1 proteins in Xenopus eggs. EMBO J. 16:1997;3320.
26. Kimura H., Nozaki N., Sugimoto K. DNA polymerase alpha associated protein P1, a murine homolog of yeast MCM3, changes its intranuclear distribution during the DNA synthetic period. EMBO J. 13:1994;4311.
27. Mahbubani H.M., Chong J.P., Chevalier S., Thommes P., Blow J.J. Cell cycle regulation of the replication licensing system. involvement of a Cdk-dependent inhibitor J Cell Biol. 136:1997;125.
28. Nurse P. Ordering S phase and M phase in the cell cycle. Cell. 79:1994;547.
29. Sherr C.J. G1 phase progression. cyclin on cue cell Cell. 79:1994;551.
30. Pines J. Cyclins and their associated cyclin-dependent kinases in the human cell cycle. Biochem Soc Trans. 21:1993;921.
31. Tamura K., Kanaoka Y., Jinno S., Nagata A., Ogiso Y., Shimizu K., Hayakawa T., Nojima H., Okayama H. Cyclin G. a new mammalian cyclin with homology to fission yeast Cig1 Oncogene. 8:1993;2113.
32. Girard F., Strausfeld U., Fernandez A., Lamb N.J.C. Cyclin A is required for the onset of DNA replication in mammalian fibroblast. Cell. 67:1991;1169.
33. Pagano M., Peppercock R., Verde C., Ansorge W., Draetta G. Cyclin A is required at two points in the human cell cycle. EMBO J. 11:1992;961.
34. Dulic V, Lees E, Reed SL (1992) Association of human cyclin E with periodic G1-S phase protein kinase. Science 257:1958.
35. Koff A., Giordano A., Desai D., Yamashita K., Harper J.W., Elledge S., Nishimoto T., Morgan D.O., Franza B.R., Roberts J.M. Formation and activation of a cyclin E-cdk2 complex during the G1 phase of the human cell cycle. Science. 257:1992;1689.
36. Meyerson M., Harlow E. Identification of G1 kinase activity for cdk6, a novel cyclin D partner. Mol Cell Biol. 14:1994;2077.
37. Bates S., Bonetta L., MacAllan D., Parry D., Holder A., Dickson C., Peters G. Cdk6 (PLSTIRE) and cdk4 (PSK-J3) are distinct subsets of the cyclin-dependent kinases that associate with cyclin D1. Oncogene. 9:1994;71.
38. Lew D.J., Dulic V., Reed S.I. Isolation of three novel human cyclins by rescue of G1 cyclin (cln) function in yeast. Cell. 66:1991;1197.
39. Xiong Y., Zhang H., Beach D., Ward D.C. D type cyclins associate with multiple protein kinases and the DNA replication and repair factor PCNA. Cell. 71:1992;505.
40. Coleman T.R., Dunphy W.G. Cdc2 regulatory factors. Curr Opin Cell Biol. 6:1994;877.
41. Mueller P.R., Coleman T.R., Kumagai A., Dunphy W.G. Mytl. a membrane-associated inhibitory kinase that phosphorylates Cdc2 on both threonine-14 and tyrosine-15 Science. 270:1995;86.
42. Pines J. p21 inhibits cyclin shock. Nature. 369:1994;520.
43. Li R., Murray A.W. Feedback control of mitosis in budding yeast. Cell. 66:1991;519.
44. Hoyt M.A., Totis L., Roberts B.T. S. cerevisiae genes required for cell cycle arrest in response to loss of microtubule function. Cell. 66:1991;507.
45. Li Y., Benezra R. Identification of a human mitotic checkpoint gene. hsMAD2 Science. 274:1996;246.
46. Taylor S.S., McKeon F. Kinetochore localization of murine Bub1 is required for normal mitotic timing and checkpoint response to spindle damage. Cell. 89:1997;727.
47. Kim S.H., Lin D.P., Matsumoto S., Kitazono A., Matsumoto T. Fission yeast Slp1. an effector of the Mad2-dependent spindle checkpoint Science. 279:1998;1045.
48. Hwang L.H., Lau L.F., Smith D.L., Mistrot C.A., Hardwick K.G., Hwang E.S., Amon A., Murray A.W. Budding yeast Cdc20. a target of the spindle checkpoint Science. 279:1998;1041.
49. Cross S.M., Sanchez C.A., Morgan C.A., Schimke M.K., Ramel S., Idzerda R.L., Raskind W.H., Reid B.J. A p53-dependent mouse spindle checkpoint. Science. 267:1995;1353.
50. Khan S.H., Wahl G.M. p53 and pRb prevent rereplication in response to microtubule inhibitors by mediating a reversible G1 arrest. Cancer Res. 58:1998;396.
51. Di Leonardo A., Khan S.H., Linke S.P., Greco V., Seidita G., Wahl G.M. DNA rereplication in the presence of mitotic spindle inhibitors in human and mouse fibroblasts lacking either p53 or pRb function. Cancer Res. 57:1997;1013.
52. Lanni J.S., Jacks T. Characterization of the p53-dependent postmitotic checkpoint following spindle disruption. Mol Cell Biol. 18:1998;1055.
53. Usui T., Yoshida M., Abek K., Osada H., Isono K., Beppu T. Uncoupled cell cycle without mitosis induced by a protein kinase inhibitor, K-252a. J Cell Biol. 115:1991;1275.
54. Hall L.L., Th'ng J.P., Guo X.W., Teplitz R.L., Bradbury E.M. A brief staurosporine treatment of mitotic cells triggers premature exit from mitosis and polyploid cell formation. Cancer Res. 56:1996;3551.
55. Coverley D., Wilkinson H.R., Downes C.S. A protein kinase-dependent block to reinitiation of DNA replication in G2 phase in mammalian cells. Exp Cell Res. 225:1996;294.
56. MacAuley A., Cross J.C., Werb Z. Reprogramming the cell cycle for endoreduplication in rodent trophoblast cells. Mol Biol Cell. 9:1998;795.
57. Bhat M.A., Philp A.V., Glover D.M., Bellen H.J. Chromatid segregation at anaphase requires the barren product, a novel chromosome-associated protein that interacts with Topoisomerase II. Cell. 87:1996;1103.
58. Kirk K.E., Harmon B.P., Reichardt I.K., Sedat J.W., Blackburn E.H. Block in anaphase chromosome separation caused by a telomerase template mutation. Science. 275:1997;1478.
59. Samejima I., Yanagida M. Bypassing anaphase by fission yeast cut9 mutation. requirement of cut9+ to initiate anaphase J Cell Biol. 127:1994;1655.
60. Lee K.S., Yuan Y.L., Kuriyama R., Erikson R.L. Plk is an M-phase-specific protein kinase and interacts with a kinesin- like protein, CHO1/MKLP-1. Mol Cell Biol. 15:1995;7143.
61. Bahler J., Pringle J.R. Pom1p, a fission yesat protein kinase that provides positional information for both polarized growth and cytokinesis. Genes Develop. 12:1998;1356.
62. Muhua L., Adames N.R., Murphy M.D., Shields C.R., Cooper J.A. A cytokinesis checkpoint requiring the yeast homologue of an APC-binding protein. Nature. 393:1998;487.
63. Balasubramanian M.K., McCollum D., Chang L., Wong K.C., Naqvi N.I., He X., Sazer S., Gould K.L. Isolation and characterization of new fission yeast cytokinesis mutants. Genetics. 149:1998;1265.
64. Eng K., Naqvi N.I., WK C., Balasubramanian M.K. Rng2p, a protein required for cytokinesis in fission yeast, is a component of the actomyosin ring and the spindle pole body. Curr Biol. 8:1998;611.
65. Yamamoto T., Horikoshi M. Defect in cytokinesis of fission yeast induced by mutation in the WD40 repeat motif of a TFIID subunit. Genes Cells. 3:1998;347.
66. Momand J., Zambetti G.P., Olson D.C., George D., Levine A.J. The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation. Cell. 69:1992;1237.
67. Oliner J.D., Pietenpol J.A., Thiagalingam S., Gyuris J., Kinzler K.W., Vogelstein B. Oncoprotein MDM2 conceals the activation domain of tumour suppressor p53. Nature. 362:1993;857.
68. Lundgren K., Montes de Oca Luna R., McNeill Y.B., Emerick E.P., Spencer B., Barfield C.R., Lozano G., Rosenberg M.P., Finlay C.A. Targeted expression of MDM2 uncouples S phase from mitosis and inhibits mammary gland development independent of p53. Genes Develop. 11:1997;714.
69. Soonpaa M.H., Koh G.Y., Pajak L., Jing S., Wang H., Franklin M.T., Kim K.K., Field L.J. Cyclin D1 overexpression promotes cardiomyocyte DNA synthesis and multinucleation in transgenic mice. J Clin Invest. 99:1997;2644.
70. Gilman J.R. Normal hemopoiesis in intrauterine and neonatal life. J Pathol. 52:1942;25.
71. Izumi T., Kawakami M., Enzan H., Ohkita T. The size of megakaryocytes in human and fetal infantile and adult hematopoiesis. Hiroshima J Med Sci. 32:1983;257.
72. Allen Graeve J., de Alarcon P. Megakaryocytopoiesis in the human fetus. Arch Dis Child. 64:1989;481.
73. de Alarcon P., Graeve J. Analysis of megakaryocyte ploidy in fetal bone marrow biopsies using a new adaptation of the feulgen technique to measure DNA content and estimate megakaryocyte ploidy from biopsy specimens. Pediatr Res. 39:1996;166.
74. Kaushansky K. Thrombopoietin. the primary regulator of platelet production Blood. 86:1995;419.
75. de Sauvage F.J., Hass P.E., Spencer S.D., Malloy B.E., Gurney A.L., Spencer S.A., Darbonne W.C., Henzel W.J., Wong S.C., Kuang W.J., Oles K.J., Hultgren B., Solberg L.A., Goeddel D.V., Eaton D.L. Stimulation of megakaryocytopoiesis and thrombopoiesis by the c-Mpl ligand. Nature. 369:1994;533.
76. Bartley T.D., Bogenberger J., Hunt P., Li Y.S., Lu H.S., Martin F., Chang M.S., Samal B., Nichol J.L., Swift S., Johnson M.J., Hsu R.-Y., Parker V.P., Suggs S., Skrine J.D., Merewether L.A., Clogston C., Hsu E., Hokom M.M., Hornkohl A., Choi E., Pangelinan M., Sun Y., Mar V., McNinch J., Simonet L., Jacobsen F., Xie C., Shutter J., Chute H., Basu R., Selander L., Trollinger D., Sieu L., Padilla D., Trail G., Elliot G., Izumi R., Covey T., Crouse J., Garcia A., Xu W., Del Castillo J., Biron J., Cole S., Hu M.C.-T., Pacifici R., Ponting I., Saris C., Wen D., Yung Y.P., Lin H., Bosselman R.A. Identification and cloning of a megakaryocyte growth and development factor that is a ligand for the cytokine receptor Mpl. Cell. 77:1994;1117.
77. Wendling F., Maraskovsky E., Debili N., Florindo C., Teepe M., Titeux M., Methia N., Breton-Gorius J., Cosman D., Vainchenker W. cMpl ligand is a humoral regulator of megakaryocytopoiesis. Nature. 369:1994;571.
78. Kaushansky K. The mpl ligand. molecular and cellular biology of the critical regulator of megakaryocyte development Stem Cells. 12:1994;91.
79. Gurney A.L., Carver-Moore K., de Sauvage F.J., Moore M.W. Thrombocytopenia in c-mpl-deficient mice. Science. 265:1994;1445.
80. Odell T.T., Jackson C.W., Reiter R.S. Generation cycle of rat megakaryocytes. Exp Cell Res. 53:1968;321.
81. Zhang Y., Wang Z., Ravid K. The cell cycle in polyploid megakaryocytes is associated with reduced activity of cyclin B1-dependent cdc2 kinase. J Biol Chem. 271:1996;4266.
82. Goyannes-Villaescuca V. Ultrastructure of endomitosis in megakaryocytes. Cell Tissue Kinetics. 2:1969;165.
83. Winkelmann M., Pfitzer P., Schneider W. Significance of polyploidy in megakaryocytes and other cells in health and tumor disease. Klin Wochen. 65:1987;1115.
84. Odell T.T. Jr., Jackson C.W. Polyploidy and maturation of rat megakaryocytes. Blood. 32:1968;102.
85. Wang Z., Zhang Y., Kamen D., Lees E., Ravid K. Cyclin D3 is essential for megakaryocytopoiesis. Blood. 86:1995;3783.
86. Nagata Y., Yoshinao M., Todokoro K. Thrombopoietin-induced polyploidization of bone marrow megakaryocytes is due to a unique regulatory mechanism in late mitosis. J Cell Biol. 139:1997;449.
87. Vitrat N., Cohen-Solal K., Pique C., LeCouedic J.P., Norol F., Larsen A.K., Katz A., Vainchenker W., Debili N. Endomitosis of human megakaryocytes are due to abortive mitosis. Blood. 91:1998;3711.
88. Gu XF, Allain A, Li L, Cramer EM, Tenza D, Caen JP, Han ZC (1993) Expression of cyclin B in megakaryocytes and cells of other hematopoietic lines. Comptes Rendus de l Academie des Sciences - Serie III, Sciences de la Vie 316:1438.
89. Datta N.S., Williams J.L., Caldwell J., Curry A.M., Ashcraft E.K., Long M.W. Novel alterations in CDK1/cyclin B1 kinase complex formation occur during the acquisition of a polyploid DNA content. Mol Biol Cell. 7:1996;209.
90. Garcia P., Cales C. Endoreplication in megakaryoblastic cell lines is accompanied by sustained expression of G1/S cyclins and downregulation of cdc25C. Oncogene. 13:1996;695.
91. Zhang Y., Wang Z., Liu D.X., Pagano M., Ravid K. Ubiquitin-dependent degradation of cyclin B is accelerated in polyploid megakaryocytes. J Biol Chem. 273:1998;1387.
92. Zachariae W., Nasmyth K. TPR proteins required for anaphase progression mediate ubiquitination of mitotic B-type cyclins in yeast. Mol Biol Cell. 7:1996;791.
93. Zimmet J.M., Ladd D., Jackson C.W., Stenberg P.E., Ravid K. A role for cyclin D3 in the endomitotic cell cycle. Mol Cell Biol. 17:1997;7248.
94. Datta N.S., Williams J.L., Long M.W. Differential modulation of G1-S-phase cyclin-dependent kinase 2/cyclin complexes occurs during the acquisition of a polyploid DNA content. Cell Growth Differ. 9:1998;639.
95. Kikuchi J., Furukawa Y., Iwase S., Terui Y., Nakamura M., Kitagawa S., Kitagawa M., Komatsu N., Miura Y. Polyploidization and functional maturation are two distinct processes during megakaryocytic differentiation. involvement of cyclin-dependent kinase inhibitor p21 in polyploidization Blood. 89:1997;3980.
96. Penington D.G., Olsen T.E. Megakaryocytes in states of altered platelet production. cell numbers, size and DNA content Br J Haematol. 18:1970;447.
97. Penington D.G., Streatfield K., Roxburgh A.E. Megakaryocytes and the heterogeneity of circulating platelets. Br J Haematol. 34:1976;639.
98. Bessman J.D. The relation of megakaryocyte ploidy to platelet volume. Am J Hematol. 16:1984;161.
99. Levin J., Bessman J.D. The inverse relation between platelet volume and platelet number. Abnormalities in hematologic disease and evidence that platelet size does not correlate with platelet age. J Lab Clin Med. 101:1983;295.
100. Corash L., Chen H.Y., Levin J., Baker G., Lu H., Mok Y. Regulation of thrombopoiesis. effects of the degree of thrombocytopenia on megakaryocyte ploidy and platelet volume Blood. 70:1987;177.
101. Corash L. The relationship between megakaryocyte ploidy and platelet volume. Blood Cells. 15:1989;81.
102. Stenberg P.E., Levin J. Ultrastructural analysis of acute immune thrombocytopenia in mice. dissociation between alterations in megakaryocytes and platelets J Cell Physiol. 141:1989;160.
103. Eldor A., Avitzour M., Or R., Hanna R., Penchas S. Prediction of haemorrhagic diathesis in thrombocytopenia by mean platelet volume. Br Med J. 285:1982;397.
104. Martin J.F., Trowbridge E.A., Salmon G., Plumb J. The biological significance of platelet volume. its relationship to bleeding time, platelet thromboxane B2 production and megakaryocyte nuclear DNA concentration Thrombosis Res. 32:1983;443.
105. Thompson C.B., Eaton K.A., Princiotta S.M., Rushin C.A., Valeri C.R. Size dependent platelet subpopulations. relationship of platelet volume to ultrastructure, enzymatic activity, and function Br J Haematol. 50:1982;509.
106. Jakubowski J.A., Thompson C.B., Vaillancourt R., Valeri C.R., Deykin D. Arachidonic acid metabolism by platelets of differing size. Br J Haematol. 53:1983;503.
107. Thompson C.B., Jakubowski J.A., Quinn P.G., Deykin D., Valeri C.R. Platelet size as a determinant of platelet function. J Lab Clin Med. 101:1983;205.
108. Thompson C.B., Jakubowski J.A., Quinn P.G., Deykin D., Valeri C.R. Platelet size and age determine platelet function independently. Blood. 63:1984;1372.
109. Haver V.M., Gear A.R. Functional fractionation of platelets. J Lab Clin Med. 97:1981;187.
110. Mazur E.M., Lindquist D.L., de Alarcon P.A., Cohen J.L. Evaluation of bone marrow megakaryocyte ploidy distributions in persons with normal and abnormal platelet counts. J Lab Clin Med. 111:1988;194.
111. Tomer A., Friese P., Conklin R., Bales W., Archer L., Harker L.A., Burstein S.A. Flow cytometric analysis of megakaryocytes from patients with abnormal platelet counts. Blood. 74:1989;594.
112. Odell T.T., Murphy J.R., Jackson C.W. Stimulation of megakaryocytopoiesis by acute thrombocytopenia in rats. Blood. 48:1976;765.
113. Odell T.T. Jr., Murphy J.R. Effects of degree of thrombocytopenia on thrombocytopoietic response. Blood. 44:1974;147.
114. Odell T.T. Jr., Jackson C.W., Reiter R.S. Depression of the megakaryocyte-platelet system in rats by transfusion of platelets. Acta Haematol. 38:1967;34.
115. Harker L.A. Regulation of thrombopoiesis. Am J Physiol. 218:1970;1376.
116. Kuter D.J., Rosenberg R.D. Regulation of megakaryocyte ploidy in vivo in the rat. Blood. 75:1990;74.
117. de Sauvage F.J., Carver-Moore K., Luoh S.M., Ryan A., Dowd M., Eaton D.L., Moore M.W. Physiological regulation of early and late stages of megakaryocytopoiesis by thrombopoietin. J Exp Med. 183:1996;651.
118. Debili N., Wendling F., Katz A., Guichard J., Breton-Gorius J., Hunt P., Vainchenker W. The Mpl-ligand or thrombopoietin or megakaryocyte growth and differentiative factor has both direct proliferative and differentiative activities on human megakaryocyte progenitors. Blood. 86:1995;2516.
119. Stoffel R., Wiestner A., Skoda R.C. Thrombopoietin in thrombocytopenic mice. evidence against regulation at the mRNA level and for a direct regulatory role of platelets Blood. 87:1996;567.
120. Fielder P.J., Gurney A.L., Stefanich E., Marian M., Moore M.W., Carver-Moore K., de Sauvage F.J. Regulation of thrombopoietin levels by c-mpl-mediated binding to platelets. Blood. 87:1996;2154.
121. Broudy VC, Lin NL, Sabath DF, Papayannopoulou T, Kaushansky K (1997) Human platelets display high affinity receptors for thrombopoietin. Blood 89:1896.
122. Chang M., Suen Y., Meng G., Buzby J.S., Bussel J., Shen V., van de Ven Cairo M.S. Differential mechanisms in the regulation of endogenous levels of thrombopoietin and interleukin-11 during thrombocytopenia. insight into the regulation of platelet production Blood. 88:1996;3354.
123. Chang M., Qian J.X., Lee S., Joubran J., Fernandez G., Nichols J., Knoppel A., Buzby J.S. Tissue uptake of circulating thrombopoietin is increased in immune-mediated compared with irradiated thrombocytopenic mice. Blood. 93:1999;2515.
124. Tomer A., Harker L.A., Burstein S.A. Flow cytometric analysis of normal human megakaryocytes. Blood. 71:1988;1244.
125. Corash L., Levin J. The relationship between megakaryocyte ploidy and platelet volume in normal and thrombocytopenic C3H mice. Exp Hematol. 18:1990;985.
126. Jackson C.W., Steward S.A., Chenaille P.J., Ashmun R.A., McDonald T.P. An analysis of megakaryocytopoiesis in the C3H mouse. an animal model whose megakaryocytes have 32N as the modal DNA class Blood. 76:1990;690.
127. Ebbe Biology of megakaryocytes. Prog Hemost Thromb. 3:1976;211.
128. Finkel H.E. Vincristine therapy. N Y State J Med. 67:1967;2474.
129. Mandel E.M., Bessler H., Djaldetti M. Effect of a low dose of vincristine on platelet production in mice. Exp Hematol. 5:1977;499.
130. Jackson C.W., Edwards C.C. Evidence that stimulation of megakaryocytopoiesis by low dose vincristine results from an effect on platelets. Br J Haematol. 36:1977;97.
131. Krizsa F., Kovacs Z., Dobay E. Effect of vincristine on the megakaryocyte system in mice. J Med. 4:1973;12.
132. Harris R.A., Pennington D.G. The effects of low-dose vincristine on megakaryocyte colony-forming cells and megakaryocyte ploidy. Br J Haematol. 57:1984;37.
133. Stenberg P.E., McDonald T.P., Jackson C.W. Disruption of microtubules in vivo by vincristine induces large membrane complexes and other cytoplasmic abnormalities in megakaryocytes and platelets of normal rats like those in human and Wistar Furth rat hereditary macrothrombocytopenias. J Cell Physiol. 162:1995;86.
134. Thiele J., Funke S., Holgado S., Choritz H., Georgii A. Megakaryopoiesis in chronic myeloproliferative diseases. A morphometric evaluation with special emphasis on primary thrombocythemia. Anal Quant Cytol. 6:1984;155.
135. Branehog I., Ridell B., Swolin B., Weinfeld A. Megakaryocyte quantifications in relation to thrombokinetics in primary thrombocythaemia and allied diseases. Scand J Haematol. 15:1975;321.
136. Briere J., Kiladjian J.J., Peynaud-Debayle E. Megakaryocytes and platelets in myeloproliferative disorders. Baillieres Clin Haematol. 10:1997;65.
137. Jacobsson S., Carneskog J., Ridell B., Wadenvik H., Swolin B., Kutti J. Flow cytometric analysis of megakaryocyte ploidy in chronic myeloproliferative disorders and reactive thrombocytosis. Eur J Haematol. 56:1996;287.
138. Kanz L., Hollen C., Friese P., Burstein S.A. Analysis of megakaryocyte ploidy in patients with thrombocytosis. Int J Cell Cloning. 8:1990;299.
139. Renner D., Queisser W. Megakaryocyte polyploidy and maturation in chronic granulocytic leukemia. Acta Haematologica. 80:1988;74.
140. Cervantes F., Colomer D., Vives-Corrons J.L., Rozman C., Montserrat E. Chronic myeloid leukemia of thrombocythemic onset. a CML subtype with distinct hematological and molecular features? Leukemia. 10:1996;1241.
141. Saito M., Takada K., Yamada T., Fujimoto J. Overexpression of granulocyte colony-stimulating factor in vivo decreases the level of polyploidization of mouse bone marrow megakaryocytes. Stem Cells. 14:1996;124.
142. Kwong Y.L., Robertson E.P., Lee C.P., Chan L.C. Dual-color flow cytometric analysis of megakaryocytic DNA ploidy in the investigation of blastic phase chronic myelogenous leukemia with rearrangement of 3q26. Cancer. 71:1993;3882.
143. Lu G, Altman AJ, A. aBP (1993) Review of the cytogenetic changes in acute megakaryoblastic leukemia: one disease or several? Cancer Genet Cytogenet 67:81.
144. Gassmann W., Loffler H. Acute megakaryoblastic leukemia. Leuk Lymph. 18(Suppl. 1):1995;69.
145. Brown A.S., Hong Y., de Belder A., Beacon H., Beeso J., Sherwood R., Edmonds M., Martin J.F., Erusalimsky J.D. Megakaryocyte ploidy and platelet changes in human diabetes and atherosclerosis. Arterioscler Thromb Vasc Biol. 17:1997;802.
146. Trowbridge E.A., Slater D.N., Kishk Y.T., Woodcock B.W., Martin J.F. Platelet production in myocardial infarction and sudden cardiac death. Thromb Haemost. 52:1984;167.
147. Kristensen S.D., Roberts K.M., Kishk Y.T., Martin J.F. Accelerated atherogenesis occurs following platelet destruction and increases in megakaryocyte size and DNA content. Eur J Clin Invest. 20:1990;239.
148. Schick B.P., Schick P.K. The effect of hypercholesterolemia on guinea pig platelets, erythrocytes and megakaryocytes. Biochim Biophys Acta. 833:1985;291.
149. Martin J.F., Slater D.N., Kishk Y.T., Trowbridge E.A. Platelet and megakaryocyte changes in cholesterol-induced experimental atherosclerosis. Arteriosclerosis. 5:1985;604.
150. Ebbe S., Maurer H. Size and ploidy of rabbit megakaryocytes in dietary hypercholesterolaemia. Comp Hematol Intern. 2:1992;208.
151. Ebbe S., Dalal K., Forte T., Tablin F. Microcytic thrombocytosis, small megakaryocytes, platelet lipids, and hyperreactivity to collagen, lymphocytopenia, eosinophilia, and low blood volume in genetically hypelipidemic rabbits. Exp Hematol. 20:1992;486.
152. Kristensen S.D., Roberts K.M., Lawry J., Martin J.F. Megakaryocyte and vascular changes in rabbits on a short-term high cholesterol diet. Atherosclerosis. 71:1988;121.
153. Brown A.S., Martin J.F. The megakaryocyte platelet system and vascular disease. Eur J Clin Invest. 24:1994;9.
154. Galitski T., Saldanha A.J., Styles C.A., Lander E.S., Fink G.R. Ploidy regulation of gene expression. Science. 285:1999;251.
155. Murray A., Hunt T. Cells and the cell cycle. Murray A., Hunt T. The cell cycle. 1993;3 Oxford University Press, New York.